David Bruce is an Associate Director in Biomarker Operations at AstraZeneca, where they have worked since 2021. Prior to this role, David served as a Clinical Trials Coordinator at Cambridge Cancer Trials from 2019 to 2021. David's career also includes a significant tenure as a Principal Scientist at Abcam from 2014 to 2019, where they focused on quality assurance in antibody development. David earned a Ph.D. in Biochemistry from The University of Dundee and a First-Class Honours B.Sc. in Biomedical Sciences (Pharmacology) from the University of Aberdeen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices